1. Mariotto, Elena, Corallo, Diana, Pantile, Marcella, Viola, Giampietro, Aveic, Sanja. 2021. BAG1 down-regulation increases chemo-sensitivity of acute lymphoblastic leukaemia cells. In Journal of cellular and molecular medicine, 25, 9060-9065. doi:10.1111/jcmm.16822. https://pubmed.ncbi.nlm.nih.gov/34402163/
2. Zhao, Borui, Qin, Xuan, Fu, Rui, Guo, Qingxiang, Zhou, Wei. 2024. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma. In Journal of controlled release : official journal of the Controlled Release Society, 368, 623-636. doi:10.1016/j.jconrel.2024.03.014. https://pubmed.ncbi.nlm.nih.gov/38479445/
3. Wu, Hongrong, Liu, Minjing, He, Yuejun, Guo, Wanbei, Guo, Qiong. 2021. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics. In BMC cancer, 21, 160. doi:10.1186/s12885-021-07874-w. https://pubmed.ncbi.nlm.nih.gov/33581726/
4. Kermer, Pawel, Köhn, Anja, Schnieder, Marlena, Liman, Jan, Dohm, Christoph Peter. 2014. BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease. In Journal of molecular neuroscience : MN, 55, 587-95. doi:10.1007/s12031-014-0396-2. https://pubmed.ncbi.nlm.nih.gov/25106480/